MusclePharm Corp — key financial figures for fiscal year 2021 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2021)

$50.0M

Net Income/Loss (FY2021)

-$12.9M

Total Assets (FY2021)

$11.2M

Total Equity (FY2021)

-$32.2M

Cash Flows from Operating Activities (FY2021)

-$8.0M

Source: MusclePharm Corp 10-K/A filing (FY2021). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.